Nextida®
Specific collagen peptide compositions for targeted benefits
Nextida is an innovative platform of specific collagen peptide compositions that deliver targeted health benefits that go beyond those traditionally associated with collagen. Built and backed by science, Nextida unlocks the next generation of unique health solutions.
Think of Nextida as a GPS for the body. Collagen acts as a language, and each peptide composition delivers a specific message. The right collagen peptide composition is like a set of exact coordinates, telling the body how and where to get back to balance.
In 2024, Rousselot launched Nextida GC, the first specific collagen peptide composition from our new Nextida platform. Nextida GC targets post-meal glucose spikes while boosting GLP-1 secretion.
Now, Nextida NxCogni expands the platform into cognitive wellbeing, delivering targeted support for daily clarity and focus.
Insights
Game-changing collagen solutions
A preventive health solution
Targets a natural mode of action
Efficacy & safety demonstrated in clinical trials
Versatile uses & applications
Decoding the collagen language
Nextida GC, the first commercialized composition from this platform
Following its identification, the composition — now known as Nextida GC — underwent rigorous preclinical and clinical testing to confirm its capacity to naturally promote GLP-1 secretion, and to lower post-meal glucose spikes. These studies validated the initial findings and laid the foundation for its official launch.
With its distinctive collagen peptide profile, Nextida GC represents a promising innovation in the metabolic health space. By supporting natural GLP-1 secretion, it offers the potential to contribute to improved glucose regulation, insulin response, and overall metabolic balance.
Additional information